.jpg)
.jpg)
.jpg)
01 Apr, 2020
Clovis Oncology: Phase 3 Study of Rubraca
Clovis Oncology, Inc. (NASDAQ: CLVS) reported the first set of data from the Phase 3 ARIEL4 study of Rebraca will take place in an oral presentation today at the Society of Gynecologic Oncology Virtual Annual Meeting on Woman’s Cancer. T..
@Newsletter
Sign Up for Weekly UpdatesOpt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!
No articles found.
.jpg){kind=small}
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).